Thyrocare Technologies Ltd - 539871 - Book Closure For 22Nd Annual General Meeting Of Our Company
Pursuant to the provisions of Section 91 of the Act, the Register of Members and Share Transfer Books of the Company will remain closed from Wednesday, July 27, 2022 to, August 03, 2022 (both days inclusive) in connection with the AGM. Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the copy of the newspaper advertisement published in Free Press Journal (English) and Pudari (Marathi). Thyrocare Technologies Ltd - 539871 - Reg. 34 (1) Annual Report.
This is with reference to our letter dated July 12, 2022 submitting copies of notice for the 22nd Annual General Meeting to be held on August 03, 2022, along with the Annual report sent to the shareholders. While reviewing the above papers we noticed some pages were left out while collating the full set. We are therefore resubmitting the notice along with corrected copy of the Annual Report. Thyrocare Technologies Ltd - 539871 - Intimation Under Regulation 34 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
This is with reference to our letter dated July 12, 2022 submitting copies of notice for the 22nd Annual General Meeting to be held on August 03, 2022, along with the Annual report sent to the shareholders. While reviewing the above papers we noticed some pages were left out while collating the full set. We are therefore resubmitting the notice along with corrected copy of the Annual Report. Thyrocare Technologies Ltd - 539871 - Reg. 34 (1) Annual Report.
This is to inform you that the 22nd Annual General Meeting of the Company will be held at 04.00 P.M. on Wednesday, August 03, 2022, at the Corporate Office of the Company situated at D-37/3, TTC Industrial Area, MIDC, Turbhe, Navi Mumbai-400 073, to transact the ordinary and special business set out in the Notice of the meeting. In this regard, pursuant to the Regulation 34 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are submitting herewith a copy of the Notice of the 22nd Annual General Meeting along with Annual Report, which is being sent to the Shareholders. Thyrocare Technologies Ltd - 539871 - 22Nd Annual General Meeting Of The Company Will Be Held On Wednesday, August 03, 2022.
This is to inform you that the 22nd Annual General Meeting of the Company will be held at 04.00 P.M. on Wednesday, August 03, 2022, at the Corporate Office of the Company situated at D-37/3, TTC Industrial Area, MIDC, Turbhe, Navi Mumbai-400 073, to transact the ordinary and special business set out in the Notice of the meeting. In this regard, pursuant to the Regulation 34 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are submitting herewith a copy of the Notice of the 22nd Annual General Meeting along with Annual Report, which is being sent to the Shareholders. Thyrocare Technologies Ltd - 539871 - Closure of Trading Window
pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, as amended, and in accordance with the Company's Code relating to prohibition of insider trading, the trading window of the Company will remain closed for trading in Company's equity shares for Directors / Designated Employees / Connected Persons covered by the said Code, with effect from July 01, 2022, and would be re-opened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter ended June 30, 2022. Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd Thyrocare Technologies Ltd - 539871 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 27, 2022 for Docon Technologies Pvt Ltd Thyrocare Technologies Ltd - 539871 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 27, 2022 for Docon Technologies Pvt Ltd